or Try an Advanced Search...

    Technical Analysis for KLTO - Klotho Neurosciences, Inc.

    Grade Last Price % Change Price Change
    F 0.34 -2.27% -0.01
    KLTO closed down 2.27 percent on Wednesday, November 20, 2024, on 31 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Down Flat
    Historical KLTO trend table...
    Date Alert Name Type % Chg
    NR7 Range Contraction 0.00%
    NR7-2 Range Contraction 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Inside Day Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    New Downtrend Bearish -2.27%
    MACD Bullish Signal Line Cross Bullish -2.27%
    NR7 Range Contraction -2.27%
    Narrow Range Bar Range Contraction -2.27%
    Inside Day Range Contraction -2.27%
    Older End-of-Day Signals for KLTO ...

       Recent Intraday Alerts

    Alert Time
    Down 5% about 22 hours ago
    Down 3% about 22 hours ago
    Down 2 % about 22 hours ago
    Down 1% about 22 hours ago
    Fell Below 10 DMA about 22 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    KLTO Chart by TradingView
    Basic chart:

    Profile

    • Earnings date: Unknown
    Klotho Neurosciences, Inc. Description

    Klotho Neurosciences, Inc. formerly ANEW MEDICAL, INC., is a Nasdaq-listed pharmaceutical company with the ticker symbol KLTO. The company specializes in the development of patented, novel disease-modifying technologies targeting the brain and central nervous system (CNS) that are seen as key developments in treating neurodegenerative and age-related disorders. The Company obtained exclusive worldwide rights to platform technologies and knowhow to develop cutting edge protein, gene and cell therapies to treat age-related pathologies such as ALS, Alzheimer’s and Parkinson’s disease, multiple sclerosis, and rare neurodegenerative diseases. The company is managed by a team of individuals and advisors that are highly experienced in medical product development and commercialization of medical products.

    Classification
    Sector: Financial Services
    Industry: Shell Companies
    Keywords: Pharmaceutical Multiple Sclerosis Platform Technologies Parkinson’s Disease

    Is KLTO a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Oct 23 Dr. Makoto Kuro-o, Pioneer of the Klotho Anti-Aging Gene, Joins Klotho Neurosciences, Inc. as Scientific Advisor
    Oct 17 Why TSMC Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
    Oct 15 Klotho Neurosciences names Peter Moriarty as COO
    Oct 15 Co-Founder of Shire Pharmaceuticals Appointed as Chief Operating Officer of Klotho Neurosciences
    Oct 10 Why BloomZ Shares Are Trading Higher By Around 64%; Here Are 20 Stocks Moving Premarket
    Sep 30 Dr. Robert Langer, Co-Founder of Moderna, Joins Scientific Advisory Board of Klotho Neurosciences, Inc. (KLTO)
    Sep 17 ANEW MEDICAL, Inc. Announces Name Change to Klotho Neurosciences, Inc.
    Aug 21 Why Keysight Technologies Shares Are Trading Higher By Around 11%; Here Are 20 Stocks Moving Premarket
    Aug 21 ANEW MEDICAL, INC. Acquires License to Needle-Free Dry Powder Autoinjector from Transfertech Sherbrooke (“TTS”)
    Aug 19 Anew Medical gets new finance chief
    See more KLTO news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 13.1
    52 Week Low 0.26
    Average Volume 237,372
    200-Day Moving Average 4.66
    50-Day Moving Average 0.56
    20-Day Moving Average 0.41
    10-Day Moving Average 0.34
    Average True Range 0.08
    RSI (14) 37.50
    ADX 26.15
    +DI 11.75
    -DI 24.32
    Chandelier Exit (Long, 3 ATRs) 0.50
    Chandelier Exit (Short, 3 ATRs) 0.49
    Upper Bollinger Bands 0.57
    Lower Bollinger Band 0.25
    Percent B (%b) 0.28
    BandWidth 77.22
    MACD Line -0.08
    MACD Signal Line -0.08
    MACD Histogram 0.0048
    Fundamentals Value
    Market Cap 2.99 Million
    Num Shares 8.8 Million
    EPS -1.27
    Price-to-Earnings (P/E) Ratio -0.27
    Price-to-Sales 0.00
    Price-to-Book 1.87
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.38
    Resistance 3 (R3) 0.38 0.36 0.37
    Resistance 2 (R2) 0.36 0.35 0.36 0.37
    Resistance 1 (R1) 0.35 0.35 0.36 0.35 0.37
    Pivot Point 0.34 0.34 0.34 0.34 0.34
    Support 1 (S1) 0.32 0.33 0.33 0.33 0.31
    Support 2 (S2) 0.31 0.32 0.31 0.31
    Support 3 (S3) 0.30 0.31 0.31
    Support 4 (S4) 0.30